Concepedia

Publication | Open Access

The Stat3/5 Signaling Biosignature in Hematopoietic Stem/Progenitor Cells Predicts Response and Outcome in Myelodysplastic Syndrome Patients Treated with Azacitidine

DOIFull Paper Access

18

Citations

28

References

2015

Year

Paraskevi Miltiades, Eleftheria Lamprianidou, Theodoros P. Vassilakopoulos, Sotirios G. Papageorgiou, Athanasios Galanopoulos, Christos K. Kontos, Panagiotis G. Adamopoulos, Evangelia Nakou, Sofia Vakalopoulou, Vassilia Garypidou,
Clinical Cancer Research

Abstract

Our findings provide a novel link among Stat3/5 signaling and MDS pathobiology and suggest that the Stat3/5 signaling biosignature may serve as both a response biomarker and treatment target.

References

YearCitations

Page 1